Global Fertility Services Market size is expected to register a CAGR of 8.99% during the forecast period, with a market value of USD 44,136.91 Million by 2025. Fertility services are procedures or treatments used to cure genetic and fertility issues and assist with conception. These services include assisted reproductive technology (ART) methods and drugs that help infertile couples in planning a family.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6281
The Global Fertility Services Market has been segmented by underlying cause and treatment.
Based on the underlying cause, the fertility services market has been segregated into female infertility and male infertility.
The Global Fertility Services Market, based on the treatment, has been segmented into ART and infertility drugs. The ART treatment has been further segmented into in-vitro fertilization (IVF), frozen embryo replacement (FER), artificial insemination, and others.
The Global Fertility Services Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Europe is expected to dominate the global fertility services market. This can be attributed to the lower fertility rate in the region and increasing IVF tourism in Spain. For instance, according to the European Society of Human Reproduction and Embryology (ESHRE), Spain is the preferred destination by foreigners for reproductive procedures, representing almost 40% of European fertility tourism, which is estimated to rise in the future. Moreover, easy reimbursement policies and increasing obesity cases are also expected to drive market growth.
The Americas market for fertility services is estimated to be the second-largest during the review period. The high number of ART procedures in the US is expected to boost the growth of the regional market. For instance, as per the data mentioned by the Centers for Disease Control and Prevention, in 2017, nearly 284,385 ART cycles were performed at 448 clinics in the US. Additionally, late pregnancies and the high adoption rate of IVF treatment are further fueling the market growth.
Asia-Pacific is estimated to be the fastest-growing market owing to the declining fertility rates in the region. According to the data suggested by the World Bank, the fertility rate in Japan decreased at a rate of 1.6 in 2016. Moreover, fertility disorders followed by favorable reimbursement scenario is also positively affecting the market growth.
The market in the Middle East & Africa is expected to witness steady growth due to the reduced ovarian reserve in women in the Middle Eastern countries.
Key Findings of the Study
- The Global Fertility Services Market is estimated to reach USD 44,136.91 Million by 2025 at a CAGR of 8.99% during the assessment period
- Europe accounted for the largest share of the global fertility services market due to the low fertility rate and increasing obesity rate
- Based on the underlying cause, the female infertility segment accounted for the largest market share of 5% in 2018
- Based on treatment type, the Assisted Reproductive Technology (ART) segment accounted for the largest market share of 21% in 2018
MRFR recognizes the following companies as the Key Players in the Global Fertility Services Market— Merck KGaA (Germany), CooperSurgical, Inc. (US), Care Fertility (UK), Ferring B.V. (Switzerland), INVO Bioscience (US), Vitrolife (Sweden), Monash IVF Group (Australia), Cook (US), FUJIFILM Irvine Scientific (US), and Kitazato Corporation (Japan).
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/fertility-services-market-6281